Movymia
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Movymia, covering 2026-04-22 to 2026-04-22. Get the full timeline:
Most recent: EMA Authorised: Movymia (teriparatide) — STADA Arzneimittel AG
1 regulatory and trial event tracked for Movymia, covering 2026-04-22 to 2026-04-22. Get the full timeline:
Most recent: EMA Authorised: Movymia (teriparatide) — STADA Arzneimittel AG